The EU’s proposed orphan and breakthrough device designations would formalise accelerated regulatory pathways for high-need medical technologies, with significant implications for conformity ...
Learn how to develop and obtain market authorisation in the EU for medicinal products, therapies and medical devices intended for human use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results